BofA maintains Buy rating on Sutro shares - Investing.com

BofA Maintains Buy Rating On Sutro Shares - Investing.com

2 weeks from now

Oct 11, 2024  · BofA Securities has kept its Buy rating and $12.00 price target for Sutro Biopharma (NASDAQ: NASDAQ: STRO), a clinical-stage drug discovery, development, and …

investing.com

BofA Maintains Buy Rating On Sutro Shares - Investing.com India

2 weeks from now

Oct 11, 2024  · BofA Securities has kept its Buy rating and $12.00 price target for Sutro Biopharma (NASDAQ: NASDAQ: STRO), a clinical-stage drug discovery, development, and …

investing.com

Sutro Biopharma Shares Rise On BofA Buy Rating, $12 Target

2 weeks from now

May 8, 2024  · The initiation of coverage by BofA Securities with a Buy rating and a $12 price target reflects confidence in Sutro Biopharma's strategic direction and the clinical development …

investing.com

BofA Securities Starts Sutro Biopharma With Buy Rating

2 weeks from now

May 8, 2024  · -- Sutro Biopharma has an average rating of buy and price targets ranging from $8 to $20, according to analysts polled by Capital IQ. Price: 4.5200, Change: +0.27, Percent …

marketscreener.com

Sutro Biopharma Shares Rise On BofA Buy Rating, $12 Target

2 weeks from now

May 8, 2024  · Sutro Biopharma shares rise on BofA Buy rating, $12 target

investing.com

Sutro Biopharma Shares Rise On BofA Buy Rating, $12 Target

2 weeks from now

May 8, 2024  · Sutro Biopharma shares rise on BofA Buy rating, $12 target

investing.com

BofA Maintains Confidence In Eli Lilly Stock Amid Strong Diabesity ...

2 weeks from now

1 day ago  · On Wednesday, BofA Securities reiterated its Buy rating on Eli Lilly shares (NYSE: LLY), maintaining a price target of $997.00.With a current market capitalization of $670.74 …

investing.com

BofA Cuts Pernod Ricard Stock Target, Maintains Buy Rating

2 weeks from now

2 days ago  · On Tuesday, BofA Securities analyst Andrea Pistacchi revised the price target for Pernod Ricard (EPA:PERP) SA (RI:FP) (OTC: PDRDY) to €126.00 from the previous €148.00. …

investing.com

Sutro Biopharma News (STRO) - Investing.com

2 weeks from now

By Investing.com • Nov 25, 2024; Sutro Biopharma earnings beat by $0.14, revenue fell short of estimates ... BofA maintains Buy rating on Sutro shares . BofA Securities has kept its Buy …

investing.com

BofA Raises Lululemon Stock Target By 14%, Maintains Buy Rating …

2 weeks from now

On Monday, BofA Securities analyst Lorraine Hutchinson increased the price target for Lululemon Athletica Inc. (NASDAQ: LULU) shares to $480 from the previous $420 while maintaining a …

investing.com

BofA Cuts Western Digital Stock Target, Maintains Buy

2 weeks from now

13 hours ago  · On Thursday, BofA Securities revised its price target for Western Digital Corp. (NASDAQ:WDC) shares, reducing it from $89.00 to $80.00, while continuing to recommend …

investing.com

BofA Raises PACCAR Stock To Buy, Price Target Lifted On Growth ...

2 weeks from now

2 days ago  · On Tuesday, BofA Securities shifted its stance on PACCAR (NASDAQ:PCAR) stock, upgrading the rating from Neutral to Buy and increasing the price target to $121.50, up from …

investing.com

BofA Maintains Buy Rating On Intellia Stock, Says Late-stage …

2 weeks from now

6 days ago  · 邏 Just 1 week into 2025: These 7 AI-picked stocks are up 9%+ each Unlock Stocks Get 100% ad-free experience BofA maintains buy rating on Intellia stock, says late-stage …

investing.com

BofA Maintains Confidence In Eli Lilly Stock Amid Strong Diabesity ...

2 weeks from now

1 day ago  · On Wednesday, BofA Securities reiterated its Buy rating on Eli Lilly shares (NYSE:LLY), maintaining a price target of $997.00. With a current market capitalization of …

investing.com

BofA Maintains AppLovin Stock Buy Rating - Investing.com

2 weeks from now

Jan 7, 2025  · On Tuesday, BofA Securities maintained a positive stance on AppLovin Corp (NASDAQ:APP), currently trading at $337.03 with a market capitalization of $114.58 billion, …

investing.com